| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Diabetes type 2 | 122 | 35 | |
| Diabetes type 1 | 40 | 10 | |
| Elevated blood sugar (hyperglycemia) | 4 | 1 | |
| Diabetic neuropathy | 2 | 1 | |
| Latent autoimmune diabetes | 2 | 1 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Low blood sugar (hypoglycemia) | 5 | |
| Bruising | 1 | |
| Elevated blood sugar (hyperglycemia) | 1 | |
| Injection site bruising | 1 | |
| Injection site redness | 1 | |
| Reactive hypoglycemia | 1 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 1 | |
| Mild | 7 | |
| None | 40 |
Member evaluations
MSgator
evaluated on May 29, 2009
- Perceived effectiveness for diabetes type 2: Major
- Side effects: Mild